Background: microRNAs (miRNAs) are small noncoding RNAs that guide degradation of mRNA and regulate protein expression. miRNA based
I
nflammatory bowel disease (IBD) includes 2 main subforms, ulcerative colitis (UC) and Crohn's disease (CD). The diagnosis of IBD includes the evaluation of patient history, clinical examination, blood tests, ileocolonoscopy, histopathological examination of intestinal biopsies, and additional imaging modalities. Diagnosis of IBD can be challenging and in particular discriminating UC from CD can be a diagnostic challenge in cases where the inflammatory lesions are restricted to the colon. It is estimated that 10% to 15% of IBD cases cannot be classified as either UC or CD and are thus categorized as indeterminate colitis. 1 Thus, biomarkers that can help the clinicians to diagnose UC and CD are warranted.
The immunopathology of IBD is characterized by defects in the intestinal barrier triggering an innate immune response to gut microbiota, which leads to activation of the adaptive immune system. Classically, CD was thought to be a Th1 driven inflammation, whereas UC was Th2 driven but more recent data suggest that this distinction is neither consistent nor sufficient. In addition to Th1 and Th2 cells, Th17 cells have been identified as important inflammatory cells in the development of IBD through secretion of proinflammatory cytokines such as IL-17A. Recently, cells of the innate immune system such as innate lymphoid cells have also been implicated in the IBD pathogenesis. 2 The overall regulation of these cell subsets is not yet fully understood.
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antibodies showing most promising results, however, diagnostic use is limited by the low sensitivity. 1, 3 In the field of proteomics several potential biomarkers have been identified showing differential expression in UC and CD, but validation in larger cohorts is required before application in IBD diagnostics. 3 Consequently, none of these markers have found their way to daily clinical practice. Increasing evidence suggests that microRNAs (miRNAs) may play an important role in the regulation of leukocyte subsets, 4 and they have been shown to be dysregulated in several immune mediated diseases such as rheumatoid arthritis, multiple sclerosis, systemic lupus erythematosus, and IBD. [5] [6] [7] [8] miRNA sequences such as miR-21, miR-31, miR-126, and miR-155 have been shown to be deregulated in colon tissue from patients with IBD as compared to healthy controls. 8 miR-21 and miR-126 are 2 of the most frequently reported upregulated sequences in UC colon tissue. [9] [10] [11] [12] In addition, miR-21 has also been found upregulated in colon tissue of patients with CD compared with controls. [12] [13] [14] It has been hypothesized that miRNAs can discriminate UC and CD, because they may contribute to the overall different immunological and pathological characteristics that are predominant in these disease entities. Recently, a study that investigated colon biopsies from patients with IBD suggested miR-19a, miR-21, miR-31, miR-146a, and miR-375 as biomarkers for distinguishing UC and CD. 15 However, general miRNA profiling analyses of IBD samples show lack of consistency in independent studies, probably because of factors such as variation in control groups, disease activity, and data normalization. 16 Most of the studies that have investigated miRNA expression in IBD have used high throughput methods such as microarray combined with RT-qPCR for validation. However, knowledge of the cellular localization of deregulated miRNA is essential to interpret the biological role of these important epigenetic regulators in the context of IBD. 17 Only, a few studies have investigated the cellular localization of the deregulated miRNAs, and using in situ hybridization (ISH) miR-21 has been shown to be upregulated predominantly in epithelial cells in the colon of patients with UC and CD. 10, 18 In contrast, miR-21 is mainly localized to fibroblast-like-cells in colorectal cancer 19 and has also been detected in various lymphocyte subtypes in peripheral blood of healthy donors. 20 The cellular localization of miR-126 has so far not been determined in IBD, but this miRNA has in other studies been shown to be specific for endothelial cells. 21, 22 More information about the cellular localization of miRNAs in the context of IBD is needed as this will provide an important link between the increasing amounts of miRNA biomarkers detected in IBD and functional studies identifying various miRNA target genes.
The primary aim of this study was to examine which cells of the colon express miR-21 and miR-126, 2 of the most frequently reported deregulated miRNAs in colon tissue of patients with IBD. miR-21 expression was examined using a combination of ISH, immunohistochemistry (IHC), and multiplex immunofluorescence staining for analysis of a number of common cellular markers. Secondly, we applied a quantitative method of ISH and investigated the correlation to traditional RTqPCR analysis for the expression of miR-21 and miR-126. The expression levels were compared between UC, CD, and the control group.
MATERIAL AND METHODS
Formalin-fixed paraffin embedded (FFPE) biopsies from 27 individuals were obtained from the pathology archive of Department of Pathology, Hospital of Southern Jutland (Table 1) . Biopsies from left colon were preferably selected for further analysis. Biopsies were grouped as UC, CD, and non-IBD control (NC) individuals based on clinical information and pathological diagnosis. The NC group consisted of individuals undergoing colonoscopy because of unspecific gastrointestinal symptoms. Endoscopic findings and histopathological analysis could not confirm IBD. Histologically these NC biopsies were described as normal tissue or as light unspecific inflammation, which is a normal finding and is considered to be the result of the colon rinsing procedure. All histopathological descriptions were performed by an experienced clinical pathologist.
Total RNA Purification
Single paraffin sections of 5 mm from each sample were placed in 1.5 mL Eppendorph tubes. RNA purification was performed using the miRNeasy FFPE Kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. In short, sections were deparaffinized in xylene and methanol after permeabilization with proteinase-K treatment and digestion with DNAse to eliminate endogenous DNA fragments that could disturb subsequent PCR reactions. Total RNA was isolated on an RNeasy MinElute spin column and finally eluted using RNAse free water. RNA yield was determined by spectrophotometry using a NanoDrop 1000 (Thermo Scientific, Waltham, MA). Three samples were excluded from further RT-qPCR analysis because of low RNA yield (all NC).
RT-qPCR
Universal reverse transcription was performed on RNA eluates using miRCURY LNA Universal RT (Exiqon, Vedbaek, Denmark) according to the manufacturer's instructions. RT-qPCR was performed using ExiLENT SYBR Green Master Mix (Exiqon) and primers for hsa-miR-21-5p hsa-miR-126-3p and hsa-miR-223-3p (Exiqon). Four potential endogenous reference genes were chosen based on literature search 23 including U6, hsa-let-7a-5p, hsa-miR-103a-3p, and hsa-miR-191-5p (Exiqon) . RT-qPCR was run on a StepOnePlus System (Applied Biosystems, Foster City, CA). Threshold and baseline settings were set manually and kept constant on all plates. All samples were run in triplicate and notemplate controls were included on all plates. Melting curve analysis was included in all runs to control for primer dimerization. During initial screening of the 4 reference genes miR103a-3p was chosen for further analysis because it showed to be the most stably expressed (data not shown). RT-qPCR for miR-21 and miR-126 was run twice for all samples to confirm results. In the first run, neighboring sections were examined by ISH, and PCR results from this dataset were thus used for correlation as described below. In the second run, sections from additional patients were obtained and PCR results from this dataset are presented below.
Chromogenic in Situ Hybridization
Paraffin sections were cut at 5 mm thickness and placed on Super Frost Ultra Plus slides (Menzel Gläser, Braunschweig, Germany). Slides were deparaffinized with xylene and through decreasing concentrations of ethanol. Slides were placed in a Tecan Freedom EVO (Tecan, Männedorf, Switzerland) automated hybridization instrument. The tissue was permeabilized by treatment with 25 mg/mL proteinase-K for 8 minutes at 378C after prehybridization in hybridization buffer (Exiqon) for 15 minutes at 378C and hybridization with miR-21-5p, miR-126-3p or scrambled probes for 60 minutes at 578C. LNA probes were double fluorescein (FAM) labeled in the 3 0 -and 5 0 -end (Exiqon) . Probe concentration was 40 nM for miR-21-5p and 20 nM for miR-126-3p. The scramble probe, with no known complementary sequences in humans, was incubated on sections at 20 or 40 nM to 3 selected slides to test for unspecific probe binding.
Next, stringent washes were performed with 5 · SSC, 1 · SSC, and 0.2 · SSC at 598C over 20 minutes. Blocking was performed with blocking buffer (0.1% Tween-20, 4% sheep serum, and 1% bovine serum albumin, 1 · PBS) for 5 minutes at 308C. The following steps were then performed: alkaline phosphatase conjugated antifluorescein antibody (Roche, Basel, Switzerland) diluted 1:800 in blocking buffer for 30 minutes at 308C, enzymatic color development with nitroblue tetrazolium and 5-bromo-4-chloro-3 0 -indolyphosphate (Roche) for 90 minutes at 308C, stoppage of enzymatic reaction with buffer containing 50 mM Tris-HCl, 150 mM NaCl, and 10 mM KCl. Nuclei were counterstained with Nuclear Fast Red, and slides were dismantled and dehydrated through increasing concentrations of ethanol. Finally slides were mounted with Eukitt Mounting Medium (Sigma-Aldrich, St. Louis, MO). Digital whole slides were obtained using a ·20 objective in a brightfield slide scanner (Axio Scan.Z1; Zeiss, Oberkochen, Germany).
Image Analysis
Image analysis was performed using VisiomorphDP software (Visiopharm, Hoersholm, Denmark). Mucosa and, when present, submucosa were included for further analysis. Tissue and staining artefacts were excluded manually. To obtain quantitative measures pixels were classified by the software based on intensity of blue and red signal, representing ISH signal and nuclear counterstain, respectively (see Fig. 1 , Supplemental Digital Content 1, http:// links.lww.com/IBD/B479). ISH signals were graded as intense blue, weak blue, and purple (blue signal overlaying red counterstain). In total, the pixel classifier was trained to separate 8 different color categories. The following parameters were obtained: intense blue fraction (iB fraction 5 intense blue area total tissue area ), total blue fraction 
Immunohistochemistry and Fluorescent Multiplex Staining
To determine cellular origin of miR-21 expressing cells in the UC tissue 3 different approaches were performed. First, conventional chromogenic IHC detection of cellular markers (CD3, CD19, CD68, CD34, CD56, and smooth muscle actin [SMA]) on neighboring sections to the sections that had undergone miR-21 ISH was performed. Second, attempts were made to combine staining of miR-21 with different cellular markers (CD3 and CD68).Third, fluorescence multiplexing by immunohistochemical staining of tissue for 3 different (CD45, CD68, and CD56) cellular markers again on neighboring sections to the section that had undergone miR-21 ISH, was performed. The following primary antibodies were used for detection of CD3, CD19, CD68, CD34, CD56, CD45, and SMA (Table 2) , respectively: anti-CD3 clone F.7.2.38, anti-CD19 clone LE-CD19, anti-CD68 clone PG-M1, anti-CD34 clone QBEnd-10, anti-CD56 clone 123C3, and anti-SMA clone1A4 (all supplied by Dako, Glostrup, Denmark). All primary antibodies were of murine origin. For multiplex immunofluorescence detection of CD45, CD56, and CD68 a Cy3-labeled secondary antimouse antibody (Jackson ImmunoResearch, West Grove, PA) was utilized. Tissue from 2 selected patients with UCshowing strong miR-21 signal was selected for further analyses.
Conventional IHC detection of all markers was performed using the EnVision Detection System (Dako) according to the manufacturer's instructions with peroxidase-catalyzed conversion of the chromogenic substrate di-amino-benzidine. Heat induced epitope retrieval was conducted at pH 9.0 for all markers, and the following dilutions of the different primary antibodies were used: anti-CD3 (1:125), anti-CD19 (1:250), anti-CD68 (1:200), anti-CD34 (1:200), anti-CD56 (1:200), and anti-SMA (1:1000).
The combined detection of miR-21 and CD68 using a fluorescence based ISH and immunohistochemical assay was performed as described previously. 24 For combined staining of miR-21 and CD3 slides from 2 selected patients with UC were first deparaffinized and then permeabilized by treatment with proteinase-K 15 mg/mL for 10 minutes at 378C. Slides were immersed in 3% hydrogen peroxide for 60 minutes to inactivate endogenous peroxidases. Probe addition with FAM labeled miR-21-5p probe (40 nM) was performed at 558C for 60 minutes, followed by stringency washes in 0.1 · SSC. The following steps were then performed: addition of blocking buffer (0.1 M Tris-HCl, 0.15 M NaCl, 10% fetal bovine serum, and 0.01% Tween-20) for 15 minutes, peroxidase conjugated sheep anti-FAM antibody (Roche) (1:400) for 60 minutes, development of fluorescence signal using a Cy5 conjugated tyramide signal amplification kit (Perkin Elmer, Waltham, MA) for 10 minutes. Slides were dismantled and mounted with ProLong Antifade Gold with DAPI (Thermo Fisher, Waltham, MA) counterstaining nuclei. Fluorescence microscopy was performed using an AxioImager.Z1 microscope (Zeiss) and post-ISH images of regions of interests (ROIs) were obtained in Cy3, FITC, DAPI, and Cy5 channels. Slides were then demounted and heat induced epitope retrieval at pH 9.0 (10 min at 978C) performed followed by blocking. Anti-CD3 primary antibody was added overnight at 48C. Cy3-labeled goat antimouse secondary antibody (Jackson ImmunoResearch) (1:200) was added for 30 minutes at room temperature (RT). Slides were dismantled and mounted again with mounting media containing DAPI. Postimmunofluorescence images were obtained at the ROIs previously identified. The resulting multiplex images for the simultaneous visualization of miR-21 and CD3 were established by overlaying the individual black and white digital images using the Overlay Images feature of the image processing software MetaMorph v.6.10 (Universal Imaging Corp., New York, NY).
For multiplex detection of CD45, CD56, and CD68 we employed a sequential immunofluorescence detection method with intermediate imaging of ROIs in the tissue followed by elution, as previously described 25 of the primary and Cy3-labeled secondary antibodies associated with the detection of the individual markers. This detection format was chosen because the 3 primary antibodies had the same murine origin and 2 of them (anti-CD45 and anti-CD56) had the same isotype. In brief, tissue sections were initially stained with hematoxylin followed by scanning of the slides in a bright-field slide scanner (Axio Scan.Z1; Zeiss). Heat induced antigen retrieval at pH 9.0 (10 min at 958C) was subsequently performed, followed by addition of blocking buffer (0.1 M Tris-HCl, 0.15 M NaCl, 10% fetal bovine serum, and 0.01% Tween-20) for 15 minutes at RT. The first primary antibody (anti-CD56, diluted 1:100) was incubated for 30 minutes at RT and after 3 washes in 1 · PBS, the Cy3-labeled antimouse secondary antibody (diluted 1:200) was added and allowed to incubate for 30 minutes at RT. After 2 washes in 1 · PBS the slide was mounted (with DAPI-staining) for epifluorescence microscopy using an AxioImager.Z1 microscope (Zeiss). Images of ROIs were acquired with a ·20/0.8 Plan-Apochromat objective in both the DAPI and the Cy3 channel. After imaging the slides were demounted and antibodies eluted by treatment with 25 nM glycine-HCl + 1% SDS, pH 2 for 60 minutes at 508C. This procedure was subsequently repeated for the detection of CD45 (anti-CD45, diluted 1:50) and CD68 (anti-CD68, diluted 1:100), respectively, with antibody elution as described in between the 2 assays. The resulting multiplex images for the simultaneous visualization of the 3 markers were established using image processing software, as described above.
Statistical Analysis
RT-qPCR data was analyzed by the 2 2DCt method 26 and data was log-transformed to yield a normal distribution. Quantification of ISH signal was performed using ln-transformed fraction estimates for iB, TB, and TBp fractions to yield a normal distribution and analyzed as continuous variables. Comparison of groups was performed using the one-way ANOVA analysis and the Bonferroni post hoc testing. The correlation between RTqPCR expression levels and ISH quantification was examined using the Pearson correlation coefficient performed on nontransformed data.
All statistics were performed using SPSS software v. 22 (IBM, New York, NY). The level of significance was set to 0.05. All graphs are presented using GraphPad Prism (GraphPad, La Jolla, CA).
Ethical Considerations
The project was approved by Danish Data Protection Agency (2008-58-035) and The Regional Scientific Ethical Committee (S-20120173) that furthermore gave exemption from obtaining informed consent from the participants.
RESULTS

Levels of miR-21 and miR-126 are Increased in UC
Initially, miRNA expression levels were determined using RT-qPCR (Fig. 1) . miR-21 was significantly increased in UC compared with NC (fold change 6.7; P , 0.05), whereas no difference was found between CD and NC. miR-21 was also significantly increased in UC compared with CD (fold change 5.8; P , 0.05).
We also observed increased miR-126 expression in UC compared with NC (fold change 2.3, P , 0.05). A tendency toward increased miR-126 in UC compared with CD was observed but did not reach statistical significance. No difference in miR-126 expression was noted between CD and NC.
Increased levels of miR-21 and miR-126 in UC compared with NC were observed in 2 separate experiments using the same sample set. In addition, miR-223 expression was examined given its well described role in inflammation and granulocyte differentiation. 27 Increased levels of miR-223 were with statistical significance observed in UC compared with NC (fold change 2.8; P , 0.05), however, this was not the case with CD compared with NC (fold change 2.7; P ¼ 0.16), although a tendency was observed (Fig. 1) . No difference was observed comparing miR-223 expression in UC and CD.
Chromogenic ISH showing miR-21 expressed in cells of the lamina propria and miR-126 confined to endothelial cells.
The morphological distribution of miR-21 and miR-126 expression was examined using chromogenic ISH. Overall miR-21 appeared most intense in UC samples compared with NC and CD. The miR-21 positive cells were in the majority of cases localized to the lamina propria predominantly in mononuclear cells and often in cell clusters near the colonic crypts (Fig. 2) . However, in a few UC cases weak epithelial expression of miR-21 was observed in confined areas of the lesions (Fig. 2G, H) . The pattern of miR-126 expression was consistent across all samples and localized to capillaries and small blood vessels in the mucosa (Fig. 3) . No staining was observed when replacing the specific LNA probes with a negative control scrambled probe having a nonspecific sequence (see Fig. 2 , Supplemental Digital Content 2, http://links.lww.com/IBD/B479).
Quantitative ISH Showing Differential Expression of miR-21 in UC and CD
To substantiate the RT-qPCR observations above, we also obtained quantitative expression estimates from the ISH-stained sections using image analysis (Fig. 4A, B) . Using iB fraction estimates, that is, the most intense blue signal, we observed increased miR-21 levels in UC compared with NC (P , 0.002) and in UC compared with CD (P , 0.005). Remarkably, the increased relative expression levels were statistically more pronounced using image analysis of ISH compared with conventional RT-qPCR.
miR-126 showed a trend toward upregulation in the UC group compared with NC and CD but did not reach statistical significance (P ¼ 0.09 and P ¼ 0.16, respectively).
Next, the correlations between RT-qPCR expression data and ISH quantification data of neighboring sections were examined (Fig. 4C, D) . A good graphical correlation was observed for miR-21 with an R 2 -value 0.403 and Pearson correlation coefficient 0.634 (P , 0.01). Conversely, a poor correlation was observed for miR-126 with an R 2 -value 0.017 and Pearson correlation coefficient 20.132. Best correlation between quantitative ISH and RT-qPCR was obtained with the iB fraction estimates and the miR-103a-normalized RT-qPCR values (data not shown).
miR-21 is Expressed by Macrophages and Possibly T Cells in UC
Given the high expression of miR-21 in cell clusters of the lamina propria in UC, we next sought to determine the cellular localization and origin of this miRNA in selected UC samples.
First, neighboring sections were immunohistochemically stained with the T-cell marker CD3, the B-cell marker CD19, and a monocyte and macrophage specific CD68 antibody. These were compared with the staining pattern of miR-21 ( Fig. 5A-D) . Alignment of stained sections suggested overlapping staining patterns of miR-21 and CD68 and possibly CD3, whereas CD19 cells showed no overlap with miR-21. Using immunofluorescence staining a similar pattern was observed, and staining of miR-21 and CD68 on the same section demonstrated direct co-localization of miR-21 and CD68 in some cells (Fig. 5E-H) . However, not all CD68 positive cells showed miR-21 expression and conversely, not all miR-21 expressing cells were CD68 positive. Additional stainings of miR-21 and CD68 from 2 patients with UCare presented in Figs. 3 and 4 , Supplemental Digital Content 3 and 4, http://links.lww.com/IBD/B479. A similar analysis visualizing miR-21 and CD3 on the same section showed that cells with the most intense miR-21 expression were CD3 negative, and weak miR-21 expression was only observed in a minor fraction of CD3 positive cells (Fig. 6) .
Next, we examined if miR-21 is expressed in lymphocyte precursors, endothelial cells, smooth muscle cells, or NK cells in UC. CD34 is an endothelial marker and a stage-specific marker of lymphocyte differentiation, SMA antibodies labels smooth muscle cells, and myofibroblasts and CD56 is a NK-cell marker. Similar comparisons of neighboring sections using CD34 and SMA (see Fig. 6 , Supplemental Digital Content 6, http://links.lww.com/ IBD/B479) or CD56 (see Fig. 7 , Supplemental Digital Content 7, http://links.lww.com/IBD/B479) did not indicate overlapping staining patterns of these markers with miR-21.
Using multiplex immunofluorescence staining of CD56, CD68, and the pan leukocyte marker CD45, the staining patterns were compared with a neighboring section with miR-21 chromogenic stain (Fig. 7) . Comparing miR-21 positive cells (Fig. 7E) with the multiplex stained section (Fig. 7H) overlapping patterns of miR-21 with CD45 and CD68 were visualized.
DISCUSSION
In summary, we analyzed the expression of miR-21 and miR-126 in colon biopsies from patients with UC, CD, and controls. Expression levels were determined using RT-qPCR and quantitative ISH. The cellular localization of miR-21 was investigated using ISH, IHC, and fluorescence multiplex staining.
In the present study, we observed elevated miR-21 levels in UC colon biopsies compared with controls. This confirms previous reports and indicates that miR-21 has the potential as a stable biomarker in UC. [9] [10] [11] [12] However, we did not observe upregulation in CD as compared with controls, although this has been reported by other groups. [12] [13] [14] The reason for this may be because of differences in control groups and disease severity. The above-mentioned studies mainly used control groups consisting of patients undergoing screening for colorectal cancer and polyps, whereas we in the present study used patients with unspecific abdominal symptoms without confirmation of IBD. In the study by Fasseu et al 13 miR-21 was found upregulated in CD colon tissue in inflamed and noninflamed areas compared with controls. In contrast, no alteration of miR-21 expression was reported in UC as compared to controls. Fasseu et al 13 applied a strict cut-off value with only miRNAs with .5-fold increased expression compared with controls being considered, thus possibly disregarding a smaller but statistically significant increase in UC compared with controls. As described below, discrepancies of miRNA expression in independent studies using RT-qPCR may also in part be explained by the use of different endogenous reference genes. Finally, the patients with CD included by Fasseu et al 13 showed relatively high degree of histopathological inflammation in inflamed areas. The noninflamed areas were obtained from the same patient at a different site in the colon. It cannot be excluded that miR-21 expression is altered in severe stages of CD compared with moderate CD. Interestingly, we demonstrated significantly increased levels of miR-21 in UC compared with CD. In line with these observations, Schaefer et al 15 proposed that miR-21, along with other miRNAs, could be useful in discriminating UC from CD because it is elevated in UC but not in CD colon tissue compared with controls. 15 Thus, miR-21 analysis may be an important tool in IBD cases, where differential diagnosis between UC and CD is difficult and important for initiation of the right treatment. As a reference miRNA, the expression of miR-223 was also examined because this miRNA is expected to be upregulated in both UC and CD, as previously shown by other groups. 13,14 miR-223 is highly expressed in myeloid cells, especially in granulocytes, 28 and serve as a regulator of neutrophil activity and other key inflammatory processes. 27 We observed increased levels of miR-223 in both UC and CD compared with NC, although upregulation in the CD group failed to reach statistical significance because of outlier data points. No significant difference was observed comparing miR-223 expression in UC and CD, but a tendency toward higher levels of miR-223 in UC was observed suggesting a lower inflammatory reaction in the CD lesions investigated in this study.
Interestingly, our results indicate that quantification of ISH using image analysis software may be superior to conventional RT-qPCR in discriminating UC and CD based on miR-21 expression. Concerning RT-qPCR of miRNA, a general problem is to identify suitable endogenous reference genes for data normalization. One of the most commonly used reference genes in miRNA research is the snRNA U6, however, this may not be an optimal choice because the data suggest that snRNA U6 is not a stably expressed transcript compared with miRNA reference gene candidates. 23 In general, different normalization strategies may account for discrepancies when comparing independent studies or techniques. When using quantification of ISH signals, the relative expression estimates were area fractions of the ISH stained cells relative to the total tissue area and thus not including an endogenous reference gene. Comparing samples using the quantitative ISH data requires standardization of parameters such as incubation times, temperatures, section thickness, and reagent concentrations, 29 however, the procedure will not compensate for potential differences in biopsy acquisition and tissue fixation. The biopsies used in this study consisted primarily of mucosa, however, submucosa was also present in a few biopsies thus possibly introducing bias when comparing relative expression estimates FIGURE 3. miR-126 ISH. ISH for miR-126 (blue stain) was performed on colon tissue biopsies. Representative images from 3 patients are shown. In all samples miR-126 was generally seen in endothelial cells (black arrows) (A, C, and E), however, the signal appeared most intense in UC samples (C). B, D, and F, showing increased magnification of (A, C, and E), respectively, areas of magnification are indicated by dashed line boxes. CD, Crohn's disease; FFPE, formalin-fixed paraffin embedded; ISH, in situ hybridization; NC, non-IBD controls; UC, Ulcerative colitis.
between samples. In the present study, an automated hybridization instrument was used ensuring that experimental parameters were kept constant.
The RT-qPCR and quantitative ISH data correlated well for miR-21 but not for miR-126. Concerning miR-126, two outlier points may, in part, be responsible for the poor correlation. Parameters that may impact the correlation include the PCR normalization strategy, which may introduce bias if the reference gene is not stably expressed between individuals, and the probe/ primer design which may introduce bias if different target sequences are measured. Notably, ISH probes detect both mature and premature miRNA forms, 30 whereas PCR primers amplify only mature forms. 31 In addition, the efficiency of the accessibility of the target may differ between the ISH and the RT-qPCR methods. For example, it is likely that the target in the tissue may be restricted for probe access because of molecular interactions with proteins and other RNA-molecules, whereas these molecular interactions during RNA-extraction for RT-qPCR analyses are eliminated to provide the target available for amplification. Furthermore, partial degradation of total RNA in formalin-fixed paraffin embedded samples is well-known, but microRNA seems to be affected to a lesser extent. 32 Such differences will obviously influence the correlation. RT-qPCR analysis of fresh frozen tissue samples may partly improve the PCR results, 33 however, such material was not available for this study. Importantly, both RTqPCR and quantitative ISH for miR-126 measured higher expression levels in UC compared with NC.
In contrast to previous reports on IBD 10, 18 we mainly observed miR-21 in cells of the lamina propria. However, miR-21 was also found in epithelial cells in a few UC samples and interestingly the sample with the most intense epithelial miR-21 stain (Fig. 2G, H) was the only sample with pathologically described ulcerations. miR-21 has been reported to control epithelial tight junction proteins with miR-21 overexpression in Caco-2 cells leading to a decrease in occludin and ZO-1 levels, thereby increasing permeability of the mucosa. RhoB was identified as the potential target gene of miR-21. 10 This suggests that epithelial miR-21 upregulation in UC could increase intestinal permeability, which is believed to be a key pathophysiological step in the development of IBD. 2 The results of miR-21 upregulation in UC compared with CD suggest that miR-21 is not just an unspecific marker of inflammation, but that it is somewhat specific to the immunopathological process of UC. In addition, Schaefer et al 15 compared miR-21 expression of endoscopically involved versus endoscopically uninvolved areas of the same patients with UC and CD showing increased expression of miR-21 in areas with endoscopically visible intestinal lesions. 15 This indicates that . miR-21 staining (blue) was seen in cell clusters under the colonic epithelium (A). IHC staining showing partially overlapping staining patterns for CD3 (B) and especially CD68 (D) compared with miR-21, however, CD19 showed minimal overlap (C). Weak epithelial staining was observed in CD68 stained sections. Multiplexing using immunofluorescence staining and ISH was performed using DAPI nuclear background stain (blue). miR-21 signal (red) was seen in cells underlying colonic epithelium. miR-21 (red) and CD68 (white) stained section showing direct colocalization in a fraction of CD68 positive cells (white arrow) (E). Single fluorescence images of the multiplex staining shown in panel (E) are presented, detecting DAPI, miR-21, and CD68, respectively (F, G, and H). FFPE, formalin-fixed paraffin embedded; IHC, immunohistochemistry; ISH, in situ hybridization; UC, ulcerative colitis. miR-21 is increased in areas of severe inflammation but most significantly in UC.
We speculated that one or more specific cell types could be responsible for the upregulation in UC and evaluated this by ISH and IHC staining of various cell type markers. Analysis of neighboring sections indicated miR-21 expression in CD68 + macrophages and possibly CD3 + T cells. miR-21 expression was also seen in CD45 + cells suggesting expression in unspecified cells of hematopoietic origin. Direct co-localization of miR-21 and CD68 was observed in some cases. Based on our results, miR-21 expression in CD19 + B-cells, CD56 + NK cells, and innate lymphoid cells seem unlikely in UC colon tissue. Overall miR-21 is expressed in multiple cells in the lamina propria in inflamed UC tissue, including macrophages and possibly T cells. To our knowledge this is the first study to visualize miR-21 expression in macrophages.
Interestingly, miR-21 has been shown to be correlated with increased levels of CD68 and nitric oxide-synthase-2 (NOS-2) in UC and CD. 34 This study reported that NO production by macrophages may induce cellular senescence in vitro and hypothesized that the increased levels of NOS-2 in the lamina propria in UC may lead to cellular senescence and DNA damage of nearby epithelial cells contributing to UC pathogenesis and predisposing carcinogenesis. In addition, miR-21 has been studied as a regulator of inflammatory pathways in the innate immune system and identified as a negative regulator of PTEN, a known tumor suppressor and suppressor of the PI3K/Akt signaling pathway. 4 The resulting increased Akt activity caused by miR-21 overexpression has been shown to increase activity of NOS in endothelial cells in vitro and increase NO production, 35 thereby possibly linking upregulation of miR-21 in macrophages in UC to oxidative stress and cellular damage contributing to UC pathogenesis.
Concerning miR-126, we observed upregulation in UC as compared to controls but no altered expression in CD, consistent with previous reports. 9, 11 In our study, ISH showed predominant miR-126 localization to endothelial cells also in UC samples. This cell-type specific pattern has also been observed in non-IBD tissue, 21, 22 and this must be taken into account when measuring miRNA expression in tissues consisting of a heterogeneous mix vascular endothelial growth factor (VEGF). It is believed to be because of an inflammation driven angiogenesis possibly triggered by increased amounts of mucosal TNF-a and other proinflammatory cytokines leading to activation of hypoxia-inducible factors, which further induces expression of VEGF. 36, 37 The endothelial specificity of miR-126 questions the relevance of the upregulation of this miRNA in UC tissue reported by many groups, because the apparent upregulation most likely is explained by the increased vascularization in the inflamed tissue and not by upregulation of miR-126 on the single-cell level. Similar concerns regarding cell-specific miRNA have been raised by Kent et al 17 concerning miRNAs described in cancer. However, miR-126 has also been implicated in the regulation of angiogenesis by its role in the VEGF regulatory network. In normal endothelial cells miR-126 act to increase vascularization by targeting Spred-1, a suppressor of the MAP kinase pathway that is activated by VEGF stimulation, and thereby potentiate the angiogenic effect of VEGF. 38 Possibly, a combination of the relatively increased density of endothelial cells in IBD, and an upregulation of miR-126 in the endothelial cells boosting angiogenesis is reflected in the increased levels of miR-126 in heterogeneous colon tissue samples as observed in UC.
In conclusion, we have shown that miR-21 is expressed in subsets of CD68 + and CD3 + cells together with so far uncharacterized cell types in the lamina propria of UC. This may provide an important link between studies identifying miR-21 as an independent biomarker in IBD and reports on the functional role of miR-21 in various cell lines. This study confirms the previous reports of increased levels of miR-21 and miR-126 in UC colon tissue and the potential of miR-21 as a biomarker in IBD. In addition, we validated these results using a quantitative ISH method also showing significantly increased levels of miR-21 in UC compared with CD. Importantly our data indicate that quantification of ISH may be similar or superior in discriminating UC and CD based on miR-21 expression compared with conventional RT-qPCR and may constitute an improved method for biomarker evaluation of colon tissue that warrants further studies in larger sample sets.
